.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Healthtrust
Novartis
Express Scripts
QuintilesIMS
Chubb
Fish and Richardson
Cipla
Baxter
McKesson

Generated: June 22, 2017

DrugPatentWatch Database Preview

MYKACET Drug Profile

« Back to Dashboard

What is the patent landscape for Mykacet, and when can generic versions of Mykacet launch?

Mykacet is a drug marketed by G And W Labs Inc and is included in two NDAs.

The generic ingredient in MYKACET is nystatin; triamcinolone acetonide. There are eight drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the nystatin; triamcinolone acetonide profile page.

Summary for Tradename: MYKACET

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list2
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MYKACET at DailyMed

Pharmacology for Tradename: MYKACET

Ingredient-typePolyenes
Drug ClassPolyene Antifungal
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
G And W Labs Inc
MYKACET
nystatin; triamcinolone acetonide
OINTMENT;TOPICAL062733-001Mar 6, 1987ATRXNoNo► Subscribe► Subscribe
G And W Labs Inc
MYKACET
nystatin; triamcinolone acetonide
CREAM;TOPICAL062367-001May 28, 1985ATRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Fish and Richardson
Harvard Business School
AstraZeneca
Deloitte
Medtronic
Novartis
Boehringer Ingelheim
US Department of Justice
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot